Second Sight Medical Products, Inc. (EYES): Earnings News

EYES – Beats EPS loss estimates by $0.01 and beats on revenues.


Key Facts Surrounding This News Item


  • EYES had a POWR Rating of C (Neutral) coming into today.
  • EYES was 11.59% above its 10-Day Moving Average coming into today.
  • EYES was 6.75% above its 20-Day Moving Average coming into today.
  • EYES was -2.58% below its 50-Day Moving Average coming into today.
  • EYES was 12.67% above its 100-Day Moving Average coming into today.
  • EYES was 30.16% above its 200-Day Moving Average coming into today.
  • EYES had returned -5.76% year-to-date leading up to today’s news, versus a +2.26% return from the benchmark S&P 500 during the same period.

More Info About Second Sight Medical Products, Inc. (EYES)


Second Sight Medical Products develops, manufactures, and markets implantable prosthetic devices to restore functional vision to blind patients in the United States, Canada, Europe, and Saudi Arabia. The company was founded in 1998 and is based in Sylmar, California. View our full EYES ticker page with ratings, news, and more.

EYES at a Glance

EYES Current POWR Rating™
Overall POWR Rating™
EYES Current Price $0.91 6.28%
More EYES Ratings, Data, and News

EYES Price Reaction

The day of this event (Mar. 7, 2018)
EYES Closing Price$1.85 2.78%
EYES Volume665,900
16.11% from avg
Leading up to this event
EYES 1-mo return8.63%
After this event
EYES 1-day return4.05%
EYES 3-day return4.76%
EYES 5-day return6.25%

EYES Price Chart


The Top Stocks For 2019

More Second Sight Medical Products, Inc. (EYES) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All EYES News
Page generated in 0.9975 seconds.